RegisterLogin

BMS-817399

CAT: 0804-HY-15546-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-15546-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BMS-817399 is a potent, selective, and orally bioavailable CCR1 antagonist. BMS-817399 exhibits CCR1 binding affinity and chemotaxis inhibition potencies of 1 and 6 nM (IC50), respectively. BMS-817399 can be used for the research of rheumatoid arthritis[1].
CAS Number
[1202400-18-7]
UNSPSC
12352005
Target
CCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ccr1-antagonist-2.html
Purity
99.83
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O[C@@](CCN1C([C@@H](C(C)C)NC(NCC(C)(O)C)=O)=O)(C(C=C2)=CC=C2Cl)C(C)(C1)C
Molecular Formula
C23H36ClN3O4
Molecular Weight
454.00
References & Citations
[1]Santella JB 3rd, et al. Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis. J Med Chem. 2014;57 (18) :7550-7564.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CCR1

Related Products

CatalogName
HY-120620-01BMS-195270
HY-139562BMS-986318
HY-108432BMS-741672
HY-145373BMS-986143
HY-14225BMS-764459
HY-117074BMS-247243
HY-120623-01BMS-284640
HY-P2021BMS 180742
HY-19667BMS-561392
HY-120625BMS-358233

Alternative Products

CatalogName
M10732-01BMS-817399
MBS386661-01BMS-806 (BMS 378806)
A11201-25BMS-806 (BMS 378806) 25mg
A11201-1BMS-806 (BMS 378806) 1mg
A11201-2BMS-806 (BMS 378806) 2mg
A11201-500BMS-806 (BMS 378806) 500mg
MBS3600518-01BMS-708163
MBS3600120-01BMS-777607
MBS3600014-01BMS-754807
MBS3602547-01BMS-189453

Popular Products